Equities

Carasent ASA

Carasent ASA

Actions
Health CareHealth Care Providers
  • Price (NOK)18.50
  • Today's Change0.10 / 0.54%
  • Shares traded48.60k
  • 1 Year change+25.00%
  • Beta--
Data delayed at least 15 minutes, as of May 24 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.

  • Revenue in NOK (TTM)250.95m
  • Net income in NOK-55.96m
  • Incorporated2001
  • Employees165.00
  • Location
    Carasent ASAc/o Advokatsenteret ASKristian August gate 14BILLINGSTAD 0164NorwayNOR
  • Phone+1 7 038902800
  • Fax+1 7 038902801
  • Websitehttps://carasent.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
W5 Solutions AB (publ)414.58m-18.22m1.00bn166.00--3.2124.392.41-1.22-1.2229.3020.780.99822.208.043,005,845.00-4.39---5.52--58.70---4.40--1.20-2.530.1919--123.84---107.57------
Micro Systemation AB (publ)419.08m15.58m1.01bn204.0067.289.5332.672.400.85910.859123.046.061.504.926.282,001,654.005.619.3110.3818.1590.3888.713.745.971.6734.320.27662.5714.876.5375.111.57-15.61-7.37
Tecnotree Oyj909.24m125.74m1.01bn892.008.070.80995.551.110.68550.68554.966.830.68--2.1889,677.239.4917.8411.0922.1993.7693.9913.9519.83--2.400.04570.009.4913.35-3.60--210.60--
Softronic AB827.96m81.41m1.07bn428.0014.003.8111.371.301.571.5715.955.761.73--4.241,949,587.0017.0415.3826.0023.3366.5867.079.839.01----0.0534101.155.072.5823.189.943.736.19
G5 Entertainment AB (publ)1.26bn116.38m1.08bn872.008.851.713.990.856914.6814.68159.4176.001.82--115.841,458,669.0016.7520.1921.1627.0767.7862.279.229.13----0.005567.54-5.73-1.8690.56-0.1928-5.0326.19
Spir Group ASA1.06bn-8.02m1.10bn354.00--1.049.951.04-0.0627-0.11658.268.150.4883--8.392,985,074.00-0.4068---0.4987--60.70---0.833----1.220.399--2.44--76.70------
Enad Global 7 AB (publ)1.84bn82.26m1.12bn688.0013.660.27393.510.61040.93560.935620.9446.650.375930.427.172,723,936.001.68-0.92551.88-1.1274.0169.904.48-2.831.4811.380.02--9.60--158.25------
OrderYOYO A/S389.38m-48.07m1.14bn200.00--3.9444.902.93-0.368-0.3682.852.080.653222.5714.971,265,210.00-8.06-16.50-10.14-23.0081.73---12.34-21.970.9265-1.730.316--69.85--35.27------
Aiforia Technologies Oyj27.53m-148.41m1.19bn79.00--5.80--43.37-0.4988-0.49880.09250.690.0742--1.8530,354.43-39.97---45.84--80.57---538.99-----279.980.2462--49.32---6.33------
Lemonsoft Oyj313.72m57.72m1.34bn220.0023.113.7717.824.260.27090.27091.471.660.629252.396.40131,355.8011.51--14.65--86.10--18.29--1.3228.980.2011--16.82--5.43------
Carasent ASA250.95m-55.96m1.34bn165.00--1.42--5.33-0.7067-0.70673.3313.060.1998--6.561,520,891.00-4.45-1.28-4.88-1.4082.0481.75-22.30-7.24----0.0491--24.9559.06-249.01--26.81--
FormPipe Software AB518.77m33.57m1.48bn263.0044.082.9914.222.850.62390.62399.649.190.6437----1,987,913.004.164.736.257.30111.05110.516.477.57----0.050560.748.265.26321.43-1.548.37-16.06
Elliptic Laboratories ASA68.32m-38.00m1.48bn75.00--4.82--21.67-0.3658-0.36580.65652.930.1954--1.35910,946.70-10.87-8.28-11.57-9.18-----55.62-44.41----0.0777--31.2310.44-15.16--23.99--
24SevenOffice Group AB350.34m-114.35m1.48bn166.00--26.18--4.23-1.66-1.665.170.84020.6629--6.75---22.29-21.25-29.50-26.6847.7346.71-33.63-44.04---20.440.0371--27.2625.2821.76--47.30--
Nordhealth As422.70m-127.79m1.57bn395.00--2.89--3.71-1.62-1.625.3512.020.3561--8.251,070,137.00-10.76---12.25--85.96---30.23------0.00--18.60--21.96------
Enea AB879.67m-571.76m1.58bn451.00--0.867119.741.80-26.61-26.6142.2785.110.2937--1.891,914,750.00-19.080.4233-21.530.5076.0575.93-64.991.18--8.560.31240.00-3.132.11-605.47--6.10--
Data as of May 24 2024. Currency figures normalised to Carasent ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

41.47%Per cent of shares held by top holders
HolderShares% Held
Aeternum Management ASas of 29 Sep 202313.32m18.42%
SEB Investment Management ABas of 29 Sep 20233.04m4.20%
Columbia Threadneedle Asset Managers Ltd.as of 31 Mar 20242.67m3.70%
Consensus Asset Management AB (Investment Management)as of 30 Jun 20232.42m3.34%
Swedbank Robur Fonder ABas of 29 Feb 20242.40m3.32%
LGT Capital Partners AG (Investment Management)as of 30 Apr 20221.75m2.42%
Aktia Fondbolag Abas of 30 Apr 20241.43m1.98%
Didner & Gerge Fonder ABas of 31 Dec 20231.35m1.87%
Schroder Investment Management Ltd.as of 30 Jun 20231.20m1.66%
Danske Invest Asset Management ASas of 30 Apr 2024416.13k0.58%
More ▼
Data from 30 Jun 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.